|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 147 studies with search of: | Emtricitabine/Tenofovir disoproxil fumarate OR Truvada[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
|
||||
| 2 | Not yet recruiting |
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
|
||||
| 3 | Active, not recruiting |
Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)
|
||||
| 4 | Active, not recruiting |
Safety and Efficacy of GS-9350-Boosted Atazanavir Compared to Ritonavir-Boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 5 | Active, not recruiting |
Study of the Safety and Efficacy of Elvitegravir/Emtricitabine/Tenofovir Disoproxil Fumarate/GS-9350 (QUAD) Versus Atripla(R) in HIV Infected, Antiretroviral Treatment-Naive Adults
|
||||
| 6 | Not yet recruiting |
A Rollover Protocol to Provide Subjects Completing the GS-US-203-0107 Study Continued Access to the Fixed Dose Combination Product Emtricitabine/Tenofovir Disoproxil Fumarate
|
||||
| 7 | Active, not recruiting |
Truvada Versus Truvada Plus HBIG in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant
|
||||
| 8 | Recruiting |
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
|
||||
| 9 | Active, not recruiting |
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
|
||||
| 10 | Active, not recruiting |
Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
|
||||
| 11 | Active, not recruiting |
Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, & Entecavir in the Treatment of Chronic HBV in Subjects w/Decompensated Liver Disease.
|
||||
| 12 | Recruiting |
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples
|
||||
| 13 | Active, not recruiting |
Intensification With Enfuvirtide in Naive HIV-Infected Patients (ANRS130)
|
||||
| 14 | Withdrawn |
A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects
|
||||
| 15 | Active, not recruiting |
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
|
||||
| 16 | Completed |
ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
|
||||
| 17 | Recruiting |
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
|
||||
| 18 | Recruiting |
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
|
||||
| 19 | Recruiting |
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
|
||||
| 20 | Recruiting |
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|